top of page

Research Articles and Other Literature

Article
Date Published
Author(s)
Link to Article
Europol Joint Report on a new psychoactive substance: Carfentanil
2017
European Monitoring Centre for Drugs and Drug Addiction
https://www.emcdda.europa.eu/system/files/publications/6502/2017.6256_EN_04-WEB.pdf
Effect of Intranasal vs Intramuscular Naloxone on Opioid Overdose A Randomized Clinical Trial
2019
Paul Dietze, PhD, Marianne Jauncey, MPH (Hons), Allison Salmon, PhD, Mohammadreza Mohebbi, PhD, Julie Latimer, BN (Hons), Ingrid van Beek, MD, Colette McGrath, MHM, and Debra Kerr, PhD
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902775/
Drug Overdose Deaths Involving Fentanyl, 2011–2016
2019
Merianne Rose Spencer, M.P.H., Margaret Warner, Ph.D., and Brigham A. Bastian, B.S., National Center for Health Statistics; James P. Trinidad, M.P.H., M.S., U.S. Food and Drug Administration; and Holly Hedegaard, M.D., M.S.P.H., National Center for Health Statistics
https://www.cdc.gov/nchs/data/nvsr/nvsr68/nvsr68_03-508.pdf?fbclid=IwAR1PDY4RTy2eXITF4expj0FLF8Nr8N5A4V_B7RlLiWlaUbsHDG-lz8JiSZU
Drug and Opioid-Involved Overdose Deaths — United States, 2017–2018
2020
Nana Wilson, PhD; Mbabazi Kariisa, PhD; Puja Seth, PhD; Herschel Smith IV, MPH; Nicole L. Davis, PhD
https://www.cdc.gov/mmwr/volumes/69/wr/mm6911a4.htm
Deaths Involving Fentanyl, Fentanyl Analogs, and U-47700 — 10 States, July–December 2016
2017
Julie K. O’Donnell, PhD, John Halpin, MD, Christine L. Mattson, PhD, Bruce A. Goldberger, PhD, and R. Matthew Gladden, PhD
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689219/
Death Rates from Unintentional and Undetermined Prescription Opioid Overdoses and Dispensing Rates of Controlled Prescription Opioid Analgesics - 2011-2015
2017
Scott K Proescholdbell, Mary E Cox, Alex Asbun
https://www.ncmedicaljournal.com/content/ncm/78/2/142.full.pdf
Characteristics of Fentanyl Overdose — Massachusetts, 2014–2016
2017
Nicholas J. Somerville, MD; Julie O’Donnell, PhD; R. Matthew Gladden, PhD; Jon E. Zibbell, PhD; Traci C. Green, PhD; Morgan Younkin, MD; Sarah Ruiz, MSW; Hermik Babakhanlou-Chase, MPH; Miranda Chan, MPH; Barry P. Callis, MSW; Janet Kuramoto-Crawford, PhD; Henry M. Nields, MD, PhD; Alexander Y. Walley, MD
https://www.cdc.gov/mmwr/volumes/66/wr/mm6614a2.htm
Vital Signs: Changes in Opioid Prescribing in the United States, 2006–2015
2017
Gery P. Guy Jr., PhD; Kun Zhang, PhD; Michele K. Bohm, MPH; Jan Losby, PhD; Brian Lewis; Randall Young, MA; Louise B. Murphy, PhD; Deborah Dowell, MD
https://www.cdc.gov/mmwr/volumes/66/wr/mm6626a4.htm
Buprenorphine physician supply: Relationship with state-level prescription opioid mortality
2017
Hannah K. Knudsen, Jennifer R. Havens, Michelle R. Lofwall, Jamie L. Studts, Sharon L. Walsh
https://www.sciencedirect.com/science/article/pii/S0376871616310304?via%3Dihub
Buprenorphine Exposures Among Children and Adolescents Reported to US Poison Control Centers
2018
Sara Post, Henry A. Spiller, Marcel J. Casavant, Thitphalak Chounthirath and Gary A. Smith
https://pediatrics.aappublications.org/content/pediatrics/142/1/e20173652.full.pdf
Association of Law Enforcement Seizures of Heroin, Fentanyl, and Carfentanil With Opioid Overdose Deaths in Ohio, 2014-2017
2019
Jon E. Zibbell, PhD, Arnie P. Aldridge, PhD, Dennis Cauchon, Jolene DeFiore-Hyrmer, PhD, MPH, and Kevin P. Conway, PhD
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902770/
An Expanding World of Novel Psychoactive Substances: Opioids
2017
Jolanta B. Zawilska
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492455/
Page 1 of 1

©2018-2026 San Benito County Opioid Task Force

Last Updated:   March 2026

bottom of page